ProAssurance Co. (NYSE:PRA) Shares Bought by Voya Investment Management LLC

Voya Investment Management LLC raised its holdings in shares of ProAssurance Co. (NYSE:PRA - Free Report) by 5.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 356,081 shares of the insurance provider's stock after buying an additional 17,959 shares during the quarter. Voya Investment Management LLC owned about 0.70% of ProAssurance worth $5,665,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Barclays PLC raised its holdings in ProAssurance by 307.5% in the 3rd quarter. Barclays PLC now owns 85,117 shares of the insurance provider's stock valued at $1,280,000 after acquiring an additional 64,228 shares during the last quarter. JPMorgan Chase & Co. increased its holdings in shares of ProAssurance by 34.8% in the third quarter. JPMorgan Chase & Co. now owns 253,175 shares of the insurance provider's stock valued at $3,808,000 after purchasing an additional 65,325 shares during the last quarter. KBC Group NV lifted its position in ProAssurance by 75.4% during the fourth quarter. KBC Group NV now owns 4,184 shares of the insurance provider's stock worth $67,000 after buying an additional 1,798 shares in the last quarter. Savant Capital LLC boosted its stake in ProAssurance by 49.6% during the fourth quarter. Savant Capital LLC now owns 45,240 shares of the insurance provider's stock worth $720,000 after buying an additional 14,991 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC grew its holdings in ProAssurance by 0.4% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 1,316,249 shares of the insurance provider's stock valued at $20,678,000 after buying an additional 4,814 shares in the last quarter. 85.58% of the stock is owned by hedge funds and other institutional investors.

ProAssurance Trading Down 0.1 %

PRA stock traded down $0.03 during mid-day trading on Friday, hitting $23.01. 624,852 shares of the company were exchanged, compared to its average volume of 432,739. ProAssurance Co. has a 12-month low of $10.76 and a 12-month high of $23.70. The firm has a market capitalization of $1.18 billion, a P/E ratio of 27.72 and a beta of -0.09. The business has a fifty day simple moving average of $20.74 and a 200-day simple moving average of $17.41. The company has a quick ratio of 0.28, a current ratio of 0.28 and a debt-to-equity ratio of 0.35.

ProAssurance (NYSE:PRA - Get Free Report) last posted its quarterly earnings data on Monday, February 24th. The insurance provider reported $0.36 earnings per share for the quarter, topping analysts' consensus estimates of $0.17 by $0.19. The firm had revenue of $287.52 million during the quarter, compared to analysts' expectations of $274.56 million. ProAssurance had a net margin of 3.71% and a return on equity of 2.65%. On average, equities research analysts predict that ProAssurance Co. will post 0.8 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

PRA has been the topic of several analyst reports. Citigroup lowered ProAssurance to a "market perform" rating in a report on Thursday, April 3rd. StockNews.com began coverage on shares of ProAssurance in a research note on Saturday. They set a "hold" rating on the stock. Raymond James cut shares of ProAssurance from a "market perform" rating to an "underperform" rating in a research note on Thursday, April 10th. Finally, Citizens Jmp lowered shares of ProAssurance from an "outperform" rating to a "market perform" rating in a research report on Thursday, April 3rd. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the company. According to MarketBeat, ProAssurance has an average rating of "Hold" and a consensus target price of $18.67.

ProAssurance Company Profile

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.